Cancer Genetics Regulated and unregulated cell proliferation L2 Flashcards

1
Q

CDK- complexes help?

A
  • CDK-cyclin complexes help regulate cell
    cycle progression (checkpoints)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Malignant tumours of cancers are:

A

AGGREGATEs of cells,
DESCENDED from an INITIAL ABERRANT FOUNDER.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Virtually ALL CANCERS of SOMATIC CELLS arise

A
  1. due to a
    SERIES OF MUTATIONS that ACCUMULATE

How?
2. Some mutations ALTER ACTIVITY OF A GENE

3., while
others ELIMINATE THE GENE’S ACTIVITY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cancer promoting mutations: 3

A
  1. INCREASE ability of cell to PROLIFERATE

2.DECREASE susceptibility of CELL TO APOPTOSIS

  1. INCREASE general MUTATION RATE in cell OR it LONGEVITY
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metastatic breast cancer …

A
  1. Metastatic breast
    cancer masses (white protrusions) growing on a human liver (crowding out
    normal cells)
  2. Light Micrograph -
    light pale-stained
    cells are cancer cells
    invading regions of
    the darker normal
    liver cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MANY DIFFERENT CELL TYPES CAN BE CONVERTED TO MALIGNANT STATE …

Is there a common theme or does each arise in
different way?

A
  1. General way - due to accumulation of mutations -
    single cell proliferates out of control
  2. Cancer cell isolated state where they operate
    without external constraint - “deaf” to signals from neighbouring cells to stop dividing or undergo apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alfred Knudson (1971) proposed Rb results from two separate
genetic defects, both necessary for cancer to develop… STEPS = 5

A
  1. Rarely, a single cell undergoes 2 somatic mutations,…
  2. …resulting in a single tumour for example, in one eye.
  3. A predisposed person inherits one mutation.
  4. some cells undergo a single somatic mutation that produces cancer.
  5. because only a single mutation is required to produce cancer, the likelihoof of its occuring twise (in both eyes for example), INCREASES.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RETINOBLASTOMA in Children…

A
  1. Rare for a single
    cell in one eye to
    undergo two successive
    mutations,
    - Retinoblastoma is
    rare and typically
    develops in only
    one eye.
  2. Children with bilateral
    retinoblastoma inherit
    one of the two
    mutations, and so
    every cell contains this
    initial mutation.
    - All that
    is required for cancer
    to develop is for one
    eye cell to undergo
    the second mutation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clonal evolution of Tumors STEPS: 4

A
  1. A cell is predisposed to proliferate at an abnormally high rate.
  2. a 2nd mutation causes the cell to divide even more RAPIDLY
  3. After 3rd mutation, the cell undergoes STRUCTURAL CHANGES.
  4. A 4th mutation causes the cell to divide UNCONTROLLABLY and invade other tissues.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cancer is the result
of a multistep process that = 5

A
  1. requires several mutations.
  2. Cells of the CLONE
    divide more
    RAPIDLY ;
  3. they soon OUTGROW other cells.
  4. More AGRESSIVE PROLIFERATION
  5. ADVANCED CANCER CELLS tend to have
    DEFECTIVE DNA REPAIR MECHANISMS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Colorectal cancer… STEPS = 9

A
  1. NORMAL CELL - loss of normal TUMOUR SUPPRESSOR gene ‘APC’
  2. A ‘polyp’ (small growth) forms on the COLON WALL
  3. A BENIGN, precancerous tumour grows.
  4. ACTIVATION OF ONCOGENE ras
  5. and ADENOMA (benign tumour) GROWS
  6. Loss of tumour - SUPPRESSOR GENE ‘p53’
  7. a CARCINOMA (malignant tumour) DEVELOPS
  8. Other changes: loss of ANTIMETASTASIS GENE
  9. The CANCER METASTASIZES (spreads to other tissue through BLOODSTREAM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mutations in multiple
genes contribute to the
progression of

A

COLORECTAL CANCER

Several distinct changes
seen in progression of
tissues from normal to
malignant state (10-35
years).

Common
mutational events in
progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EXPLAIN Cancer cells exhibit aneuploidy -

EXAMPLE?

A
  1. Cancer cells exhibit aneuploidy
    - possess chromosome
    abnormalities, extra, missing and chromosome
    rearrangements.
  2. Colon cancer cell, mar = major chromosome rearrangements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mutations in cancer cells
Two general kinds of mutations associated with tumours

list them:

A
  1. Proto-oncogene mutations

2.Tumour Suppressor gene mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

EXPLAIN PROTO-ONCOGENE MUTATIONS

A
  1. Mutation only required in one allele for tumour
    formation
    (Dominant-acting mutation)
  2. The gene in its normal mutated form = ONCOGENE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

EXPLAIN Tumour Suppressor gene mutations:

A

For cancer to occur, both alleles of gene must be
mutated and have no activity

(Recessive-acting
mutation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oncogenes: Increase growth and division EXPLAIN - 2

A
  1. Proto-oncogenes normally produce factors that stimulate cell division
  2. MUTANT ALLELES (ONCOGENES) tend to be DOMINANT; one copy of the mutant is sufficient to INDUCE EXCESSIVE CELL PROLIFERATION.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tumour-suppressor genes: Decrease growth and division EXPLAIN - 2

A
  1. Tumour-suppressor genes normally produce factors that INHIBIT CELL DIVISION
  2. Mutant alleles are RECESSIVE (both alleles must be mutated to produce Excessive cell proliferation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

EXPLAIN

Loss of heterozygosity – Inactivation of remaining WT allele

A

People heterozygous for tumour-suppressor gene are predisposed to CANCER.

(Aa) - this genotype is heterozygous for a tumour suppressor gene.

CHROMOSOME DELETION
leads to

(_a) loss of wild-type allele, in this case through chromosome deletion …CAUSES LOSS OF TUMOUR SUPPRESSOR ACTIVITY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ONCOGENES

define PROTO-ONCOGENES:

A
  1. encode proteins that regulate normal cell proliferation

(eg. Signaling, control of
cell cycle, or apoptosis)

  1. Either positive or negative regulators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

EXPLAIN proto-oncogenes
…Accumulate mutations to become oncogenes….4 WAYS

A

Accumulate mutations to become oncogenes:

1.– POINT MUTATIONS alter structure/function (eg. ras)

2 – LOSS OF PROTEIN domains resulting from DELETION

3.– GENE FUSIONS, often from TRANSLOCATION (eg. Bcr-ABL)

  1. – MUTATION may result in MIS-EXPRESSION (eg.
    Bcl2-enhancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ras signal transduction pathway = 4

A
  1. Binding of growth factor to the receptor causes a conformational change and the addition of phosphate groups.
  2. Adaptor molecules bind to the receptor and link to Ras.
    Ras binds GTP and is activated.
  3. Activated Ras activated Raf, which activates MEK, which activates MAP kinase.
  4. Activated MAP KInase moves into the nucleus and activates transcription factors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ras signal transduction pathway MUTATED

A

95% of pancreas tumours and 45% of colorectal tumors

  1. Point mutation of an intracellular signal transducer.
  2. Single base pair mutation of ‘ras’ gene creates oncoprotein - bladder cancer.
  3. Ras: G-protein in signal transduction, normally functions between active and inactive states
  4. Mutation causes onco-protein to always bind
    GTP….always active
  5. Continuously propagates cell proliferation signal
24
Q

INACTIVE RAS TP ACTIVE RAS

A
  1. Inactive Ras
  2. GDP
    - GTP — Sos interaction stimulates GDP-GTP exchange. —GDP.
  3. Activate Ras —GTP
  4. Ras oncoprotein is blocked here. SIGNAL REMAINS ON.
    - does not go back to INACTIVE Ras.
  5. Continuously activates downstream serine/threonine kinase.
25
Q

EXPLAIN Structurally altered oncoprotein caused by gene fusion

A
  1. eg Philadelphia chromosome (chronic myelogenous leukemia)
    Translocation between chromosomes 9 and 22
  2. Cause fusion of 2 genes - BCR1 and c-ABL. The c-ABL proto-oncogene
    encodes a protein kinase that participates in the signal transduction
    pathway (a growth factor - cell proliferation).
  3. bcr1-c-abl fusion onco-protein permanent protein kinase activity

SLIDE 17

26
Q

Some oncoproteins are identical in structure to normal proteins, but the

A

mutation causes the protein to be mis-expressed,

eg B cell tumour

27
Q

No protein fusion rather chromosomal rearrangement causes

A

gene near one
breakpoint to be turned on in wrong tissue

28
Q

Explain Follicular Lymphoma…4

A

1 - translocation between chromosomes 14 and 18.

2.Near chr 14 is a transcriptional enhancer for a B cell-specific gene.

  1. Enhancer element fused with bcl-2 gene, negative regulator of apoptosis.
  2. Large amounts bcl-2 expressed in B cells, blocks apoptosis, these B cells have an unusually long life in which to accumulate mutations that promote
    cell proliferation and Follicular lymphoma
29
Q

Explain: Some tumour-suppressor genes encode

= 3

A
  1. negative
    regulators of cell cycle, eg the Rb protein.
  2. positive regulators of apoptosis, eg.
    P53
  3. Others are indirect players, normal role in the
    repair of damaged DNA or in controlling cellular
    longevity
30
Q

Tumour-suppressor genes

Knockout of protein : p53

= 7

A
  1. Knockout of protein: that inhibits cell proliferation and
    promotes apoptosis
  2. p53 (refers to protein with mass of 53 kDa)
    eg of tumour suppressor gene, mutations associated with many types of tumours
  3. ~50% of all tumours have mutated form
  4. normal p53 is a transcription factor that is activated in response to DNA damage
  5. Prevents cell cycle progression to allow repair
  6. Causes severely damaged cells to undergo
    apoptosis
  7. mutated form eliminates apoptotic response, allowing
    damaged cells to survive, elevating mutation level
31
Q

Viruses are associated with some cancers:

RETROVIRUS INSERTION to RNA into CELL…4

A
  1. A retrovirus inserts its RNA into the cell, the viral RNA undergoes reverse transcription and inserts into the host Chromosome next to a proto-oncogene.
  2. when the VIRUS REPRODUCES, the PROTO-ONCOGENE is INCORPORATED into the VIRUS.
  3. In repeated rounds of VIRAL infection and, REPRODUCTION, the proto-oncogene becomes rearranged or Mutated or Both, …

4…. producing an oncogene that is INSERTED back into the HOST CHROMOSOME.

32
Q

Viruses are associated with some cancers:

RETROVIRUS INFECTS CELL…3

A
  1. A retrovirus infects a cell..
  2. …and the provirus inserts near a proto-oncogene.
  3. the strong VIRAL PROMOTER stimulates over-expression of the PROTO-ONCOGENE.
33
Q

Retroviruses cause cancer by: 2

A

1 -mutating and rearranging proto-oncogenes

2 - inserting strong promoters near protooncogenes

34
Q

Viruses are associated with some cancers: EXPLAIN

Eg. Human papillomavirus (DNA virus) & cervical cancer

A
  1. 70% cervical cancer
    • inactivates Rb and p53
    • Epstein-Barr virus & Burkitts lymphoma
    • Human T-Lymphotropic Virus (HTLV-1) & T cell leukemia (retrovirus)
35
Q

Cancer complexities:

A
  1. Numerous mutations promote tumour growth.
  2. Mutations alter normal processes that govern
    proliferation and apoptosis
  3. Different cancers have different phenotypes
    with respect to rate of proliferation, ability to
    metastasize, etc
36
Q

Different cancers have different phenotypes ……Differences caused by: 2

A
  1. differences in somatic cell progenitor
  2. differences in types and severity of mutations
37
Q

Main events contributing to tumour formation:

A

Increased cell proliferation and cell survival (decreased apoptosis)

38
Q

Main events contributing to tumour formation: pathway

A

Gain-of-function dominant oncogene mutations

1 - Mitogen pathway

  1. CELL PROLIFERATION
  2. LOSS OF FUNCTION MUTATIONS IN TUMOUR-SUPPRESSOR GENES
  • GROWTH INHIBITOR PATHWAYS
  • p53 pathways
    (irreparable DNA damage)

LOSS OF FUNCTION MUTATIONS IN TUMOUR-SUPPRESSOR GENES

  1. Irreparable DNA damage
  2. p53 pathways + Apoptosis
  3. APOPTOSIS
  4. survical factor pathways
39
Q

Hanahan and Weinberg (2000) Cell. Jan
7;100(1):57-70.

hallmarks of cancer

A

> 15000 citations!!

~30 years in the making

40
Q

6 major hallmarks of cancer:

A
  1. Evading apoptosis
  2. Self-sufficiency growth signals
  3. insensitivity to anti-growth signals
  4. Tissue invasion and metastasis
  5. Limitless replicative potential
  6. sustained angiogenesis
41
Q

6 major hallmarks of cancer: EXPLAIN WHY

A

Most, if not all, cancers have acquired the same set of functional capabilities, albeit through various mechanistic strategies

42
Q

Understanding Self Sufficiency in growth signals = 5

A
  1. Normal cells take up mitogenic signals from
    neighbours, but tumor cells generate their own
    growth signals.
  2. Eg. Platelet derived growth factor made by glioblastoma or tumor growth factor alpha
    by sarcoma
  3. Tumor cells overexpress receptors in permanently active forms
  4. Tumor cells have mutations in the downstream signalling molecules.
  5. Eg. Ras-MAPK pathway
    mutated in 25% of all cancers
43
Q

explain Insensitivity to anti-growth signals

A
  1. Normal cells can be pushed into a quiescent/differentiated state.
  2. In G1, cells constantly monitor the environment to make decisions about division
44
Q

Insensitivity to anti-growth signals:

For cells to maintain anti-differentiation: 3

A

1 – In embryonic development Myc-Max
transcription factor keeps cells pluripotent

2 – With maturity, cells make Mad-Max and this
triggers differentiation

3 – Cancers reactivate Myc, making more Myc-Max again

45
Q

UNDERSTANDINGEvading apoptosis = 3

A
  1. Cell cannot undergo apoptosis, much longer
    lifetime, accumulate proliferation-promoting
    mutations
  2. Sorts of damage taking place in tumour cell would otherwise induce the self-destruct pathway
  3. Tumour cells would not be able to survive unless
    apoptosis is prevented by mutations
46
Q

What are The first 3 hallmarks:

A
  1. self-sufficiency in growth signals,
  2. ignoring
    anti-growth signals
  3. and evading apoptosis
47
Q

What are the second 3 hallmarks:

A
  1. Sustained angiogenesis
  2. limitless replicative potential
  3. tissue invasion and metastasis
48
Q

explain Tissue invasion and metastasis: 3

A
  1. Changing physical coupling of tumor cells to the stroma:
    activation of extracellular
    proteases
  2. Epithelial to mesenchymal transition is key
  3. Mesenchymal cells
    lose E-cadherin –the molecule that bridges cell-cell contacts
49
Q

explain Limitless replicative potential:

A
  1. 80-90% of cancers
    upregulate telomerase

– the enzyme that lengthens telomeres

50
Q

Explain SUSTAINED ANGIOGENESIS:

A
  1. All cells in a
    tissue need to be ~100µm from a blood vessel
  2. Without blood:
    hypoxia and nutrient starvation
51
Q

UPDATED Hallmarks of Cancer

A

10 hallmarks in total

52
Q

THE + 4 Hallmarks ..

A

EMERGING HALLMARKS

  1. Deregulating cellular energetics
  2. Avoiding immune destruction

ENABLING CHARACTERISTICS
3. Tumour promoting inflammation

  1. Genome instability and mutation
53
Q

explain Avoiding immune destruction:

A

emerging hallmarks

  1. Evade detection and attack by the immune system
54
Q

explain Deregulating cellular energetics…

A

emerging hallmarks

  1. Alter metabolism to
    support rapid growth
55
Q

explain genome instability and mutation

A

enabling characteristics

  1. Accumulate genetic
    mutations that drives further cancer development
56
Q

explain tumour promoting inflammation:

A

enabling characteristics

1.Chronic inflammation supports cancer growth